BTIG initiates coverage of Pulse Biosciences with Buy rating, $70 price target
BTIG initiated coverage on Pulse Biosciences's stock with a rating of Buy and a price target of $70.00.The price target implies an upside of 32.9% from the Sep 22 close of $52.69.Key takeaways from the analyst noteInnovative Technology with Strong Clinical Results: Pulse Biosciences has developed a…